American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: https://www.sciepub.com/journal/ajmcr Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2024, 12(9), 141-143
DOI: 10.12691/ajmcr-12-9-3
Open AccessCase Report

Intravascular Large B–cell Lymphoma Diagnosed Incidentally after a Renal Biopsy: A Case Report of a Rare and Elusive Malignancy

Sikander Chohan1, and Shahina Patel2

1Wayne State University School of Medicine, Detroit, MI, USA

2Henry Ford Hospital, Wyandotte, MI, USA

Pub. Date: September 26, 2024

Cite this paper:
Sikander Chohan and Shahina Patel. Intravascular Large B–cell Lymphoma Diagnosed Incidentally after a Renal Biopsy: A Case Report of a Rare and Elusive Malignancy. American Journal of Medical Case Reports. 2024; 12(9):141-143. doi: 10.12691/ajmcr-12-9-3

Abstract

Intravascular large B-cell lymphoma (IVLBCL) is a form of diffuse large B-cell lymphoma (DLBCL) characterized by the proliferation of malignant B-cells within the lumen of small blood vessels. With an incidence rate of one in a million, it is one of the rarest forms of DLBCL. This rarity, combined with the absence of extravascular tumor masses or circulating malignant cells in the peripheral blood and potential involvement of multiple organs, makes the diagnosis of IVLBCL exceptionally difficult. We discuss that case of a 64-year-old female who presented with symptoms of altered mental status, expressive aphasia, and fatigue. She was also found to have normocytic anemia with elevated hemolysis markers. Over a period of months, her neurological symptoms and anemia with elevated hemolysis markers persisted despite repeated hematological, infectious, and neurological workup. Overall, we hope to highlight the unusual clinical manifestations of IVLBCL, as early diagnosis and treatment can be lifesaving.

Keywords:
lymphoma B-cell hematological malignancy oncology renal malignancy

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014; 3(4): 1010-1024.
 
[2]  Piccaluga PP, Paolini S, Campidelli C, Vianelli N, Bolondi L. A Western Case of Intravascular Large B-Cell Lymphoma as Unusual Cause of Persistent Fever. Case Rep Hematol. 2019; 2019: 1480710. Published 2019 Nov 16.
 
[3]  Ponzoni M, Campo E, Nakamura S. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood. 2018; 132(15): 1561-1567.
 
[4]  Ponzoni M, Ferreri AJ. Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes?. Hematol Oncol. 2006; 24(3): 105-112.
 
[5]  Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014; 3(4): 1010-1024.
 
[6]  Mukherjee A, Ibrahim IF. Intravascular large B-cell lymphoma: an elusive diagnosis with challenging management. J Community Support Oncol. 2018; 16(6):e280-e282.
 
[7]  Roy AM, Pandey Y, Middleton D, Broadfoot B, Sasapu A, Veeraputhiran M. Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma. Cureus. 2021; 13(7): e16459. Published 2021 Jul 18.
 
[8]  Li Q, Li J, Yang K, et al. EBV-positive intravascular large B-cell lymphoma of the liver: a case report and literature review. Diagn Pathol. 2020; 15(1): 72. Published 2020 Jun 8.
 
[9]  Sawa N, Ubara Y, Katori H, et al. Renal intravascular large B-cell lymphoma localized only within peritubular capillaries. Report of a case. Intern Med. 2007; 46(10): 657-662.
 
[10]  Bai X, Li X, Wan L, Wang G, Jia N, Geng J. Intravascular large B-cell lymphoma of the kidney: a case report. Diagn Pathol. 2011; 6: 86. Published 2011 Sep 23.
 
[11]  Kado H, Hatta T, Ueno R, et al. Nihon Jinzo Gakkai Shi. 2011; 53(7): 1046-1052.
 
[12]  Desclaux A, Lazaro E, Pinaquy JB, Yacoub M, Viallard JF. Renal Intravascular Large B-cell Lymphoma: A Case Report and Review of the Literature. Intern Med. 2017; 56(7): 827-833.
 
[13]  Ferreri AJ, Dognini GP, Bairey O, et al. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma. Br J Haematol. 2008; 143(2): 253-257.
 
[14]  Rajyaguru DJ, Bhaskar C, Borgert AJ, Smith A, Parsons B. Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database. Leuk Lymphoma. 2017; 58(9): 1-9.
 
[15]  Woo KA, Yoo D, Jung KH. Intravascular lymphoma as a Potential Cause of Recurrent Embolic Stroke of Undetermined Source. J Clin Neurol. 2019; 15(3):415-417.